Skip to content

Peer-Led Healthy Lifestyle Program in Supportive Housing

Peer-Led Healthy Lifestyle Program in Supportive Housing Agencies

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02175641
Enrollment
314
Registered
2014-06-26
Start date
2015-07-31
Completion date
2019-07-31
Last updated
2021-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Keywords

Healthy lifestyle Intervention, Serious Mental Illness, Effectiveness trial, Supportive housing, Racial and Ethnic Health Disparities

Brief summary

This goal of this randomized controlled effectiveness trial is to compare the effectiveness of a peer-led health lifestyle intervention (Peer GLB) versus usual care services in supportive housing agencies in New York City and Philadelphia serving diverse clients with serious mental illness who are overweight or obese. The intervention follows the Group Lifestyle Balance curriculum derived from the Diabetes Prevention Program and that has been shown to help people achieve clinically significant weight loss (equal to or greater than 5% weight loss of initial weight). The intervention will be delivered by trained peer-specialists employed at the supportive housing agencies and supervised by the study team. Peer GLB is a 12-month group intervention that focuses helping people lose weight by improving people's diet and increasing their physical activity and consists of weekly core group sessions (3 mo.), bi-monthly transitional group sessions (3 mo.), and maintenance monthly sessions (6 mo.). We plan to enroll 300 clients with serious mental illness who are overweight/obese (BMI equal to or greater than 25) from our two supportive housing agencies. Clients will be randomized to either the Peer-led healthy lifestyle intervention or usual care conditions. The primary outcome for this study is achieving clinically significant weight loss (equal to or greater than 5% weight loss from baseline weight) at 12 and 18 months post randomization. The secondary outcomes for this study include overall reductions in weight, waist circumference, blood pressure, and improvements in physical activity, self-efficacy, recovery and health-related quality of life. Repeated assessments will be at baseline, 6, 12 and 18 month post randomization. Primary Hypothesis: Peer GLB participants will have a higher proportion of persons achieving clinically significant weight loss (equal to or greater than 5% weight loss) at 12 and 18 months than UC participants. Secondary Hypothesis: At 6, 12, and 18 months post-randomization, there will be significant reductions in average weight, waist circumference, blood pressure, and significant improvements in physical activity, self-efficacy, recovery, and health-related quality of life in Peer GLB compared to UC.

Interventions

BEHAVIORALPeer-Led Group Lifestyle Balance

The intervention follows the Group Lifestyle Balance curriculum derived from the Diabetes Prevention Program and The intervention will be delivered by trained peer-specialists employed at the supportive housing agencies and supervised by the study team. Peer GLB is a 12-month group intervention that focuses helping people lose weight by improving people's diet and increasing their physical activity and consists of weekly core group sessions (3 mo.), bi-monthly transitional group sessions (3 mo.), and maintenance monthly sessions (6 mo.).

BEHAVIORALUsual Care Services

The usual care condition encompasses the regular services offered at supportive housing agencies to help clients with their physical health and wellness.

Sponsors

National Institute of Mental Health (NIMH)
CollaboratorNIH
Washington University School of Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male or female,18 years of age or older, of any race/ethnicity, who are English and/or Spanish speakers. * Chart diagnosis of a serious mental illness (SMI; e.g., schizophrenia, bipolar disorder, schizoaffective disorders, major depression). * Overweight/obese as determined by a Body Mass Index (BMI) equal to or greater than 25 (kg/m2) at the time of recruitment. * Able and willing to give informed consent and participate in the intervention. * Received a medical clearance from a primary care or medical provider to participate in light-to-moderate physical activity (e.g., 150 minutes a week of brisk walking).

Exclusion criteria

* Need for detoxification services at the time of recruitment. * Pose a danger to self or others at the time of recruitment. * Have medical conditions that contraindicate their participation in a healthy lifestyle program focusing on weight loss and physical activity, such as active cancer treatment, liver failure, history of anorexia nervosa, cardiovascular event \[e.g., unstable angina, myocardial infraction\] within the past 6 months, untreated exercise- induced asthma, walking limitations preventing participation in exercise, and pregnant or planning a pregnancy during study period. * Fail a capacity-to-consent questionnaire. * Cognitive impairment as detected by the Mini-Cog Examination

Design outcomes

Primary

MeasureTime frameDescription
Clinically Significant Weight LossBaseline to 18 MonthsPercentage of participants that achieve equal to or greater than 5% weight loss in lb from baseline at 12 and 18th months

Secondary

MeasureTime frameDescription
Overall Reduction in Waist Circumference Measures to the Nearest cm From Baseline to 6, 12 and 18 MonthsAt study endpoint (18 months).Waist circumference measured by a trained research assistant to the nearest 0.1 cm with an anthropometric tape, in a horizontal plane 1 cm above the navel in light indoor clothing.
Overall Reductions in Systolic Blood Pressure From Baseline, 6, 12 and 18 MonthsAt study endpoint (18 months).Blood pressure assessed on the right arm of participants after they rest quietly in a seated position for at least 5 minutes, using a validated automated sphygmomanometer.
Self-Efficacy for ExerciseAt study endpoint (18 months).Self-efficacy for exercise was measured with a three-item scale assessing a person's confidence that they can engage in physical activity. The scores from this scale range from 1 to 10 with higher scores indicating higher self-efficacy.
Overall Reduction in Weight in lb From Baseline to 6, 12 and 18 MonthsAt study endpoint (18 months).Weight (in pounds) was measured by a trained research assistant with a calibrated digital scale (participants wore indoor clothing without shoes).
Health-related Quality of LifeAt study endpoint (18-months).The 12-Item Short-Form Health Survey (SF-12) was used to capture participants health-related quality of life. The Physical Composite Score derived from the SF-12 is an indicator of health-related quality of life with scores that range from 0 to 100 with higher scores indicating higher health-related quality of life.
6-Minutes Walking TestAt study endpoint (18-months).The 6-minutes Walking Test is an objective measure of functional exercise capacity that captures the distance (in meters) that participants walk at a normal pace along a flat and straight course for 6 minutes.
Change From Baseline in Recovery Using the Recovery Assessment Scale (RAS).At study endpoint (18 months).The Recovery Assessment Scale is a 24-item measure that captures different aspects of recovery and produces a total recovery score ranging from 1 to 5 with higher scores indicating higher recovery.

Countries

United States

Participant flow

Participants by arm

ArmCount
Peer-led Group Lifestyle Balance
Group-based behavioral healthy lifestyle program Peer-Led Group Lifestyle Balance: The intervention follows the Group Lifestyle Balance curriculum derived from the Diabetes Prevention Program and The intervention will be delivered by trained peer-specialists employed at the supportive housing agencies and supervised by the study team. Peer GLB is a 12-month group intervention that focuses helping people lose weight by improving people's diet and increasing their physical activity and consists of weekly core group sessions (3 mo.), bi-monthly transitional group sessions (3 mo.), and maintenance monthly sessions (6 mo.). Usual Care Services: The usual care condition encompasses the regular services offered at supportive housing agencies to help clients with their physical health and wellness.
157
Usual Care Services
Usual wellness and health care services offered to clients at the two supportive housing agencies. Usual Care Services: The usual care condition encompasses the regular services offered at supportive housing agencies to help clients with their physical health and wellness.
157
Total314

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyDeath34
Overall StudyDeveloped Contraindicated Condition80
Overall StudyDischarged from Supportive Housing Agenc1315
Overall StudyLost to Follow-up44
Overall StudyWithdrawal by Subject74

Baseline characteristics

CharacteristicTotalUsual Care ServicesPeer-led Group Lifestyle Balance
Age, Continuous48.65 years
STANDARD_DEVIATION 11.56
48.81 years
STANDARD_DEVIATION 11.6
48.50 years
STANDARD_DEVIATION 11.56
Race/Ethnicity, Customized
Hispanic
39 Participants26 Participants13 Participants
Race/Ethnicity, Customized
Non-Hispanic Black
181 Participants77 Participants104 Participants
Race/Ethnicity, Customized
Non-Hispanic White
57 Participants29 Participants28 Participants
Race/Ethnicity, Customized
Other
37 Participants25 Participants12 Participants
Sex: Female, Male
Female
133 Participants66 Participants67 Participants
Sex: Female, Male
Male
181 Participants91 Participants90 Participants
Weight218.79 Pounds
STANDARD_DEVIATION 54.01
211.84 Pounds
STANDARD_DEVIATION 48.83
225.75 Pounds
STANDARD_DEVIATION 58.07

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
3 / 1574 / 157
other
Total, other adverse events
0 / 1570 / 157
serious
Total, serious adverse events
21 / 15721 / 157

Outcome results

Primary

Clinically Significant Weight Loss

Percentage of participants that achieve equal to or greater than 5% weight loss in lb from baseline at 12 and 18th months

Time frame: Baseline to 18 Months

Population: Participants enrolled in the trial and randomized to either Peer-led Group Lifestyle Balance or Usual Care Services

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Peer-led Group Lifestyle BalanceClinically Significant Weight Loss39 Participants
Usual Care ServicesClinically Significant Weight Loss40 Participants
p-value: >0.0595% CI: [0.62, 1.84]Regression, Logistic
Secondary

6-Minutes Walking Test

The 6-minutes Walking Test is an objective measure of functional exercise capacity that captures the distance (in meters) that participants walk at a normal pace along a flat and straight course for 6 minutes.

Time frame: At study endpoint (18-months).

Population: Participants enrolled in the trial and randomized to either Peer-led Group Lifestyle Balance or Usual Care Services.

ArmMeasureValue (MEAN)Dispersion
Peer-led Group Lifestyle Balance6-Minutes Walking Test315.83 metersStandard Error 95.97
Usual Care Services6-Minutes Walking Test318.16 metersStandard Error 93.38
p-value: 0.24Mixed Models Analysis
Secondary

Change From Baseline in Recovery Using the Recovery Assessment Scale (RAS).

The Recovery Assessment Scale is a 24-item measure that captures different aspects of recovery and produces a total recovery score ranging from 1 to 5 with higher scores indicating higher recovery.

Time frame: At study endpoint (18 months).

Population: Participants enrolled in the trial and randomized to either Peer-led Group Lifestyle Balance or Usual Care Services.

ArmMeasureValue (MEAN)Dispersion
Peer-led Group Lifestyle BalanceChange From Baseline in Recovery Using the Recovery Assessment Scale (RAS).4.26 score on a scaleStandard Deviation 0.64
Usual Care ServicesChange From Baseline in Recovery Using the Recovery Assessment Scale (RAS).4.26 score on a scaleStandard Deviation 0.57
p-value: 0.39Mixed Models Analysis
Secondary

Health-related Quality of Life

The 12-Item Short-Form Health Survey (SF-12) was used to capture participants health-related quality of life. The Physical Composite Score derived from the SF-12 is an indicator of health-related quality of life with scores that range from 0 to 100 with higher scores indicating higher health-related quality of life.

Time frame: At study endpoint (18-months).

Population: Participants enrolled in the trial and randomized to either Peer-led Group Lifestyle Balance or Usual Care Services.

ArmMeasureValue (MEAN)Dispersion
Peer-led Group Lifestyle BalanceHealth-related Quality of Life44.81 score on a scaleStandard Deviation 10.36
Usual Care ServicesHealth-related Quality of Life45.71 score on a scaleStandard Deviation 10.26
p-value: 0.52Mixed Models Analysis
Secondary

Overall Reduction in Waist Circumference Measures to the Nearest cm From Baseline to 6, 12 and 18 Months

Waist circumference measured by a trained research assistant to the nearest 0.1 cm with an anthropometric tape, in a horizontal plane 1 cm above the navel in light indoor clothing.

Time frame: At study endpoint (18 months).

Population: Participants enrolled in the trial and randomized to either Peer-led Group Lifestyle Balance or Usual Care Services.

ArmMeasureValue (MEAN)Dispersion
Peer-led Group Lifestyle BalanceOverall Reduction in Waist Circumference Measures to the Nearest cm From Baseline to 6, 12 and 18 Months114.61 centimeters (CM)Standard Deviation 18.84
Usual Care ServicesOverall Reduction in Waist Circumference Measures to the Nearest cm From Baseline to 6, 12 and 18 Months110.38 centimeters (CM)Standard Deviation 16.91
p-value: 0.91Mixed Models Analysis
Secondary

Overall Reduction in Weight in lb From Baseline to 6, 12 and 18 Months

Weight (in pounds) was measured by a trained research assistant with a calibrated digital scale (participants wore indoor clothing without shoes).

Time frame: At study endpoint (18 months).

Population: Participants enrolled in the trial and randomized to either Peer-led Group Lifestyle Balance or Usual Care Services. Results presented are weight at the study endpoint (18-months).

ArmMeasureValue (MEAN)Dispersion
Peer-led Group Lifestyle BalanceOverall Reduction in Weight in lb From Baseline to 6, 12 and 18 Months226.04 lbStandard Deviation 62.81
Usual Care ServicesOverall Reduction in Weight in lb From Baseline to 6, 12 and 18 Months209.51 lbStandard Deviation 50.41
p-value: 0.804Mixed Models Analysis
Secondary

Overall Reductions in Systolic Blood Pressure From Baseline, 6, 12 and 18 Months

Blood pressure assessed on the right arm of participants after they rest quietly in a seated position for at least 5 minutes, using a validated automated sphygmomanometer.

Time frame: At study endpoint (18 months).

Population: Participants enrolled in the trial and randomized to either Peer-led Group Lifestyle Balance or Usual Care Services.

ArmMeasureValue (MEAN)Dispersion
Peer-led Group Lifestyle BalanceOverall Reductions in Systolic Blood Pressure From Baseline, 6, 12 and 18 Months129.52 Millimeters of mercury (mmHg)Standard Deviation 17.7
Usual Care ServicesOverall Reductions in Systolic Blood Pressure From Baseline, 6, 12 and 18 Months128.28 Millimeters of mercury (mmHg)Standard Deviation 19.13
p-value: 0.64Mixed Models Analysis
Secondary

Self-Efficacy for Exercise

Self-efficacy for exercise was measured with a three-item scale assessing a person's confidence that they can engage in physical activity. The scores from this scale range from 1 to 10 with higher scores indicating higher self-efficacy.

Time frame: At study endpoint (18 months).

Population: Participants enrolled in the trial and randomized to either Peer-led Group Lifestyle Balance or Usual Care Services.

ArmMeasureValue (MEAN)Dispersion
Peer-led Group Lifestyle BalanceSelf-Efficacy for Exercise6.73 Score on a scaleStandard Deviation 2.58
Usual Care ServicesSelf-Efficacy for Exercise6.89 Score on a scaleStandard Deviation 2.32
p-value: 0.38Mixed Models Analysis

Source: ClinicalTrials.gov · Data processed: Mar 15, 2026